Opinion
Video
Author(s):
The expert panel continues the discussion with thoughts on gaps in our understanding and application of MRD testing for colorectal cancer and a look to the future, highlighting potential advancements.
CHMP Recommends Approval of Nivolumab/Ipilimumab in MSI-H/dMMR mCRC
Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors
Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC
Cancer Centers Launch Cancer AI Alliance to Unlock Discoveries, Transform Care Using Cancer Data and Applied AI
OncLive’s October Roundup of Key FDA Approvals in Oncology
Dr Caimi on Early Data for LMY-920 in R/R B-Cell NHL
Navigating a “Sea Change” in Frontline Urothelial Carcinoma Treatment
Dr Scalici on Data for IMNN-001 Plus SOC Chemotherapy in Advanced Ovarian Cancer
Dr Lin on the Safety of NKTR-255 in Enhancing Immune Recovery Post-Chemoradiation in Locally Advanced NSCLC